Lobby organisation
Insulet International
Business / industry · Health & pharma · HQ: United Kingdom · Transparency Register entry
As of 9 September 2026, Insulet International appears in 3 declared MEP meetings (3 different MEPs), most often with European People's Party.
In their own words
“Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 3 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2025–2025. Bar length is relative to its busiest year (3 in 2025). All meetings were in one calendar year.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 3 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 12 Mar 2025 | Sirpa Pietikäinen | Diabetes type 1 innovations |
| 3 Feb 2025 | András Tivadar Kulja | Improving access to advanced insulin delivery technology for people living with diabetes. |
| 3 Feb 2025 | Vytenis Povilas Andriukaitis | EU health policy |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.